Embolism and thrombosis — ICD-10 documentation and coding guidance
Customize your policy alerts
Sign up for all independence_administrators policy alerts
Know when independence_administrators releases new policies or updates existing guidance.
Monitor payer policy activity
Provides ICD-10 documentation and coding guidance for embolism and thrombosis (including DVT and PE), and documentation best practices for coding acute, chronic, and history of events; intended for clinicians and coding staff working with Independence Administrators members.
No material clinical or coverage changes in this revision.
Documentation-driven coding criteria
Documentation-driven coding criteria
Documentation and coding criteria to support coding decisions for embolism and thrombosis:
ALL of the following must be documented to code an active/current embolism or thrombosis
Type of event
- Pulmonary embolism (PE) — specify acute vs chronic, and whether with or without acute cor pulmonale
- Deep vein thrombosis (DVT) or other specified site — specify vein involved and laterality for chronic DVT coding (5th and 6th characters)
- Acuity: document whether the event is acute or chronic (repeat radiologic studies confirming persistent clot > 4 weeks required to define chronic DVT)
- Provoked vs unprovoked status of the event
- Anticoagulation treatment: document current anticoagulant use and duration of therapy (document duration in your note)
- Treatment rationale when duration exceeds usual acute windows: if treatment > 3 months for PE or > 6 months for DVT, include clear rationale why therapy is ongoing; otherwise code as history
If long-term anticoagulation is present
- Use Z79.0- or Z79.01 to indicate long-term (current) use of anticoagulants as applicable
- If anticoagulation extends beyond acute coding windows but is clearly clinically indicated, continue to code as acute/current with documentation of rationale
ICD-10 coding guidance
| I26.99 | Other pulmonary embolism without acute cor pulmonale |
| Z86.711 | Personal history of pulmonary embolism |
| I82.432 | Acute embolism and thrombosis of left popliteal vein |
| Z86.718 | Personal history of other venous thrombosis and embolism |
| I82.5- | Chronic DVT codes (5th character for vein involved; 6th character for laterality) |
| I82.532 | Chronic embolism and thrombosis left popliteal vein |
| Z79.01 | Long-term (current) use anticoagulants |
Documentation requirements and actions for providers
Required documentation elements for embolism/thrombosis coding
Document the specific type of event (PE vs. DVT and other specified site), acuity (acute vs. chronic, and if acute note presence/absence of acute cor pulmonale), whether the event was provoked or unprovoked, the anticoagulation treatment and current anticoagulation status, and the length of treatment. If treatment extends beyond typical acute windows (greater than 3 months for PE or greater than 6 months for DVT) include clear clinical rationale for continued anticoagulation; absent such rationale, code as history of rather than active.
- Specify type: pulmonary embolism (PE) or deep vein thrombosis (DVT) and other specified site.
- For PE: indicate acute vs chronic and whether acute cor pulmonale is present or absent.
- State whether the event was provoked or unprovoked.
- Document anticoagulation treatment: current status and exact length of treatment.
- If treatment >3 months for PE (or beyond typical acute window for DVT), provide documented rationale; otherwise code as history (use Z79.0- / Z79.01 for long-term/current anticoagulant use as applicable).
Key definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.